Immunophenotypic analysis of peripheral blood mononuclear cells undergoing in vitro apoptosis after isolation from human immunodeficiency virus-infected children

Blood

Volumn 92, Issue 11, 1998, Pages 4230-4237

  McCloskey, Thomas W ^a   Bakshi, Saroj ^a   Than, Soe ^a   Arman, Parisa ^a   Pahwa, Savita ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

EID: 0032402169     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4230.423k22_4230_4237     Document Type: Article

References (64)

1. Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC: Activation induced death by apoptosis in CD4 T cells from HIV infected asymptomatic individuals. J Exp Med 175:331, 1992
2. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F: Programmed death of T cells in HIV infection. Science 257:217, 1992
3. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S: Accelerated apoptosis in PBMC from HIV infected patients and in CD4 crosslinked PBMC from normal individuals. Blood 82:3392, 1993
4. Lauener RP, Huttner S, Buisson M, Hossle JP, Albisetti M, Seigneurin JM, Seger RA, Nadal D: T cell death by apoptosis in vertically HIV infected children coincides with expansion of CD8+ IL-2 receptor-HLA DR+ T cells: Sign of a possible role for herpes viruses as cofactors. Blood 86:1400, 1995
5. Baumler CB, Bohler T, Herr I, Benner A, Krammer PH, Debatin KM: Activation of the CD95 system in T cells from HIV infected children. Blood 88:1741, 1996
6. McCloskey TW, Oyaizu N, Bakshi S, Kowalski R, Kohn N, Pahwa S: CD95 expression and apoptosis during pediatric HIV infection: Early upregulation of CD95 expression. Clin Immunol Immunupathol 87:33, 1998
7. Noraz N, Gozlan J, Corbeil J, Brunner T, Spector SA: HIV induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas/Fas ligand. AIDS 11:1671, 1997
8. Finkel TH, Williams GT, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV and SIV infected lymph nodes. Nat Med 1:129, 1995
9. Herbein G, Lint CV, Lovett JL, Verdin E: Distinct mechanisms trigger apoptosis in HIV infected and in uninfected bystander T lymphocytes. J Virol 72:660, 1998
10. Newell MK, Haughn LJ, Maroun CR, Julius MH: Death of mature T cells by separate ligation of CD4 and the T cell receptor for antigen. Nature 347:286, 1990
11. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S: Crosslinking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing IFN gamma and TNF alpha secretion. Blood 84:2622, 1994
12. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH: Crosslinking CD4 by HIV gp120 primes T cells for activation induced apoptosis. J Exp Med 176:1099, 1992
13. Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadenn N, Pilling D, Pett S, Grundy JE, Janossy G: The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections: The role of apoptosis in T cell memory. J Exp Med 178:427, 1993
14. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA, Akbar AN: The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 24:892, 1994
15. Adachi Y, Oyaizu N, Than S, McCloskey TW, Pahwa S: IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: Correlation with its abiltiy to block culture induced down modulation of Bcl-2. J Immunol 157:4184, 1996
16. Boudet F, Lecoeur H, Gougeon ML: Apoptosis assocated with ex vivo downregualtion of Bcl-2 and upregulation of Fas in potential cytotoxic CDS T lymphocytes during HIV infection. J Immunol 156:2282, 1996
17. Gougeon ML. Lecoeur H, Dulioust A, Enouf MG, Crouvoisier M, Goujard C, Debord T, Montagnier L: Programmed cell death in peripheral lymphocytes from HIV infected persons; Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 156:3509, 1996
18. McCloskey TW, Cavaliere T, Bakshi S, Harper R, Fagin J, Kohn N, Pahwa S: Immunophenotyping of T lymphocytes by three color flow cytometry in healthy newborns, children, and adults. Clin Immunol Immunopathol 84:46, 1997
19. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S: Rapid and simple PCR assay for quantitation of HIV RNA in plasma; Application to acute retroviral infection. J Clin Mierobiol 32:292, 1994
20. Giorgi JV, Detels R: T cell subset alterations in HIV infected homosexual men; NIAID multicenter AIDS cohort study. Clin Immunol Immunopathol 52:10, 1989
21. Prince HE, Jensen ER; Three color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection. J Acquir Immune Defic Syndr 4:1227, 1991
22. Froebel KS, Doherty KV, Whitelaw JA, Hague RA, Mok JY, Bird AC: Increased expression of the CD45RO memory antigen on T cells in HIV infected children. AIDS 5:97, 1991
23. Bohler T, Nedel S, Debatin KM: CD95 induced apoptosis contributes to loss of primed memory but not resting naive T cells in children infected with HIV. Pediatr Res 41:878, 1997
24. Meyaard L, Otto SA, Keet IPM, Roos MTL, Miedema F: Programmed death of T cells in HIV infection: No correlation with progression to disease, J Clin Invest 93:982, 1994
25. Gougeon ML, Leceoeur H, Boudet F, Ledru E, Marzabal S, Boullier S, Roue R, Nagata S, Heeney J: Lack of chronic immune activation in HIV infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 induced apoptosis and preservation of a T helper 1 phenotype. J Immunol 158:2964, 1997
26. Truman JP, Ericson ML, Seebold CJMC, Charron DJ, Mooney NA: Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 6:887, 1994
27. Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PI; Selective increase of activation antigens HLA DR and CD38 on CD4 CD45RO T lymphocytes during HIV infection. Clin Exp Immunol 95:436, 1994
28. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R: Elevated levels of CD38 CD8 T cells in HIV infection add to the prognostic value of low CD4 T cell levels: Results of 6 years of followup. J Acquie Immune Defic Syndr 6:904, 1993
29. Schlesinger M, Peters V, Jiang JD, Roboz JP, Bekesi JG: Increased expression of activation markers on CD8 lymphocytes in children with HIV infection. Pediatr Res 38:390, 1995
30. Marshall SP, Hultin P, Bertolli J, O'Rourke S, Kobayashi R, Kobayashi AL, Giorgi JV, Bryson Y, Stiehm ER: Activation and differentiation antigens on T cells of healthy, at risk, and HIV infected children. J Acquir Immune Defic Syndr 6:984, 1993
31. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF: Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T cell lineage. Proc Natl Acad Sci USA 77:1588, 1980
32. Saukkonen JJ, Kornfeld H, Herman JS: Expansion of a CD8+CD28-cell population in the blood and lung of HIV positive patients, J Acquir Immune Defic Syndr 6:1194, 1993
33. Caruso A, Cantalamessa A, Licenziati S, Peroni L, Prati E, Martinelli F, Canaris AD, Folghera S, Gorla R, Balsari A, Cattaneo R, Turano A: Expression of CD28 on CD8 and CD4 lymphocytes during HIV infection. Scand J Immunol 40:485, 1994
34. Sperling AI, Auger JA, Ehst BD, Rulifson IC, Thompson CB, Bluestone JA: CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J Immunol 157:3909, 1996
35. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3:87, 1995
36. Brugnoni D, Prati E, Malacarne F, Gorla R, Airo P, Cattaneo R: The primary response to HIV infection is characterized by an expansion of activated CD8+ CD28-cells. AIDS 10:104. 1996
37. Borthwick NJ, Bofill M, Hassan I, Panayiotidid P, Janossy G, Salmon M, Akbar AN: Factors that influence activated CD8 T cell apoptosis in patients with acute herpervirus infections: Loss of costimulatory molecules CD28, CD5, and CD6 but relative maintenence of Bax and Bcl-x expression. Immunology 88:508, 1996
38. Fiorentino S, Dalod M, Olive D, Guillet JG, Gomard E: Predominant involvement of CD8+CD28-lymphoeytes in HIV specific cytotoxic activity. J Virol 70:2022, 1996
39. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV: Upregulation of Fas ligand expression by HIV in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 70:199, 1996
40. Estaquier J, Tanaka M, Suda T, Nugata S, Golstein P, Ameisen JC: Fas mediated apoptosis of CD4 and CD8 T cells from HIV infected persons: Differential in vitro preventive effect of cytokines and protease antagonists. Blood 87:4959, 1996
41. Badley AD, Dockrell D, Simpson M, Schut R, Lynch DH, Leibson P, Paya CV: Macrophage dependent apoptosis of CD4 T lymphocytes from HIV infected individuals is mediated by FasL and TNF. J Exp Med 185:55, 1997
42. Yang Y, Liu ZH, Ware CF, Ashwell JD: A cysteine protease inhibitor prevents activation induced T cell apoptosis and death of peripheral blood cells from HIV infected individuals by inhibiting upregulation of Fas ligand. Blood 89:550, 1997
43. Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP: Role of Fas ligand and receptor in the mechanism of T cell depletion in AIDS: Effect on CD4 lymphocyte depletion and HIV replication. Blood 89:1357, 1997
44. McCloskey TW, Oyaizu N, Kaplan M, Puhwa S: Expression of the Fas antigen in patients infected with HIV. Cytometry 22:111, 1995
45. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA: Fas antigen Stimulation induces marked apoptosis of T lymphocytes in HIV infected individuals. J Exp Med 181:2029, 1995
46. Glynn JM, McElligott DL, Mosier DE: Apoptosis induced by HIV infection in H9 T cells is blocked by ICE family protease inhibition but not by a Fas antagonist. J Immunol 157:2754, 1996
47. Katsikis PD, Ojeda MEG, Wunderlich ES, Smith CA, Yagita H, Okumura K, Kayagaki N, Alderson M, Herzenberg LA, Herzenberg LA: Activation induced peripheral blood T cell apoptosis is Fas independent in HIV infected individuals. Int Immunol 8:1311, 1996
48. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231, 1993
49. Owen-Schaub LB, Yonehara S, Crump WL, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement, Cell Immunol' 140:197, 1992
50. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH: Autocrine T cell suicide mediated by Apo-1. Nature 373:438, 1995
51. Brunner T, Mogil RJ, Larface D, Yoo NJ, Muhboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell autonomous Fas/Fas ligand interaction mediates activation induced apoptosis in T cell hybridomas. Nature 373:441, 1995
52. Ju ST, Panka DJ, Cui H, Ettinger R, Khatib ME, Sherr DH, Stanger BZ, Rothstein AM: Fas/FasL interactions required for programmed cell death after T cell activation. Nature 373:444, 1995
53. Wang ZQ, Dudhane A, Orlikcnvsky T, Clarke K, Li X, Darzynkiewicz Z, Hoffmann MK: CD4 engagement induces Fas antigen dependent apoptosis of T cells in vivo. Eur J Immunol 24:1549, 1994
54. Desbarats J, Freed JH, Campbell PA, Newell MK; Fas expression and death mediating function are induced by CD4 crosslinking on CD4 T cells. Proc Natl Acad Sci USA 93:11014, 1996
55. Sieg S, Smith D, Yildirim Z, Kaplan D; Fas ligand deficiency in HIV disease. Proc Natl Acad Sci USA 94:5860, 1997
56. Ohnimus H, Heinkelein M, Jassoy C: Apoptotic cell death upon contact of CD4 T lymphocytes with HIV glycoprotein expressing cells is mediated by caspases by bypasses CD95 and TNF receptor. J Immunol 159:5246, 1997
57. Pan G, Ni J, Wei YF, Yu GL, Gentz R, Dixit V; An antagonist decoy receptor and a death domain containing receptor For TRAIL. Science 277:815, 1997
58. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J: TRAIL receptors 1 and 2 signal FADD dependent apoptosis and activate NF-kappaB. Immunity 7:831,1997
59. Katsikis PD, Ojeda MEG, Roca JFT, Tijoe IM, Smith CA, Herzenberg LA, Herzenberg LA; IL-1beta converting enzyme like protease involvement in Fas induced and activation induced peripheral blood T cell apoptosis in HIV infection: TNF related apoptosis inducing ligand can mediate activation induced T cell death in HIV infection. J Exp Med 186:1365, 1997
60. Jeremias I, Herr I, Boehler T, Debatin KM: TRAIL/Apo-2 ligand induced apoptosis in human T cells. Eur J Immunol 28:143, 1998
61. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Feinberg JE, Balfour HH, Deyton LR, Chodakewitz JA, Fischl MA: A controlled trial of two nucloside analogues plus indinavir in persons with HIV infection and CD4 counts of 200 per cubic millimeter or less. N Engl J Med 337:725, 1997
62. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA: Treatment with indinavir, zidovudine, and lamivudine in adults with HIV infection and prior antiretroviral therapy. N Engl J Med 337:734, 1997
63. Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang ZQ, Mills R, McDade H, Goudsmit J, Danner SA, Haase AT: Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV infection. Science 276:960, 1997
64. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J: Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease. Science 277:112, 1997